Proto Labs - PRLB Stock Forecast, Price & News

2 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Proto Labs in the last year. There are currently 1 sell rating and 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "hold" PRLB shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in PRLB, but not buy additional shares or sell existing shares.
View PRLB analyst ratings or view top-rated stocks.

2 brokerages have issued 12-month target prices for Proto Labs' shares. Their PRLB share price forecasts range from $20.00 to $29.00. On average, they expect the company's stock price to reach $24.50 in the next year. This suggests that the stock has a possible downside of 16.4%.
View analysts price targets for PRLB or view top-rated stocks among Wall Street analysts.

Proto Labs' stock was trading at $25.53 at the beginning of the year. Since then, PRLB stock has increased by 14.8% and is now trading at $29.30.
View the best growth stocks for 2023 here.

The company is scheduled to release its next quarterly earnings announcement on Friday, February 10th 2023.
View our PRLB earnings forecast.

Proto Labs, Inc. (NYSE:PRLB) announced its quarterly earnings data on Friday, November, 4th. The industrial products company reported $0.14 EPS for the quarter, missing the consensus estimate of $0.24 by $0.10. The industrial products company had revenue of $121.72 million for the quarter, compared to analyst estimates of $125.09 million. Proto Labs had a trailing twelve-month return on equity of 2.86% and a net margin of 4.74%.

Proto Labs issued an update on its fourth quarter 2022 earnings guidance on Friday, November, 18th. The company provided earnings per share (EPS) guidance of $0.18-$0.26 for the period, compared to the consensus estimate of $0.43. The company issued revenue guidance of $107.00 million-$115.00 million, compared to the consensus revenue estimate of $124.63 million.

90 employees have rated Proto Labs Chief Executive Officer Victoria Holt on Glassdoor.com. Victoria Holt has an approval rating of 97% among the company's employees. This puts Victoria Holt in the top 30% of approval ratings compared to other CEOs of publicly-traded companies.

Based on aggregate information from My MarketBeat watchlists, some companies that other Proto Labs investors own include NVIDIA (NVDA), Tesla (TSLA), Brainstorm Cell Therapeutics (BCLI), Netflix (NFLX), Gilead Sciences (GILD), QUALCOMM (QCOM), Xilinx (XLNX), Advanced Micro Devices (AMD), Walt Disney (DIS) and Block (SQ).

Proto Labs trades on the New York Stock Exchange (NYSE) under the ticker symbol "PRLB."

Proto Labs' stock is owned by many different retail and institutional investors. Top institutional shareholders include Assenagon Asset Management S.A. (1.55%), ARK Investment Management LLC (1.33%), National Bank of Canada FI (0.08%), Allspring Global Investments Holdings LLC (0.08%), Yousif Capital Management LLC (0.06%) and Comerica Bank (0.06%). Insiders that own company stock include Arthur R Baker III, John B Goodman, Rainer Gawlick, Robert Bodor, Sven Wehrwein and Victoria M Holt.
View institutional ownership trends.

Shares of PRLB stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of PRLB stock can currently be purchased for approximately $29.30.

Proto Labs (NYSE:PRLB) has a market capitalization of $794.53 million and generates $488.10 million in revenue each year. The industrial products company earns $33.37 million in net income (profit) each year or $0.85 on an earnings per share basis.

The company employs 2,663 workers across the globe.

Proto Labs' mailing address is 5540 Pioneer Creek Drive, Maple Plain MN, 55359. The official website for the company is www.protolabs.com. The industrial products company can be reached via phone at (763) 479-3680, via email at daniel.schumacher@protolabs.com, or via fax at 763-479-2679.